• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化幼儿中铜绿假单胞菌的获得与清除

Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis.

作者信息

Douglas T A, Brennan S, Gard S, Berry L, Gangell C, Stick S M, Clements B S, Sly P D

机构信息

Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia Perth, Western Australia.

出版信息

Eur Respir J. 2009 Feb;33(2):305-11. doi: 10.1183/09031936.00043108. Epub 2008 Nov 14.

DOI:10.1183/09031936.00043108
PMID:19010992
Abstract

When do infants and young children with cystic fibrosis acquire infection with Pseudomonas aeruginosa? Can this be eradicated when first detected? Children <6 yrs of age participated in an annual bronchoalveolar lavage (BAL)-based microbiological surveillance programme in Perth, Australia. When P. aeruginosa was detected, an eradication programme using combination treatment with i.v., oral and nebulised antibiotics was undertaken. Repeat BAL was performed 3 months following treatment, to assess eradication success. P. aeruginosa was detected in 33 (28.4%) children; median (range) age at detection was 30.5 (3.3-71.4) months. P. aeruginosa was mucoid at detection in six (18.2%) out of 33 patients and associated with respiratory symptoms in 16 (48.5%) out of 33 children. In total, 26 children underwent eradication therapy, with P. aeruginosa eradicated in 20 (77%) out of 26 following one eradication cycle and in three (total 88%) additional children following a second cycle. Eradication was associated with a significant decrease in neutrophil elastase and interleukin-1beta in BAL fluid 12 months post eradication. Eradication of Pseudomonas aeruginosa infection is achievable in young children with cystic fibrosis for up to 5 yrs using combination i.v., oral and nebulised antibiotic therapy and is associated with reduced pulmonary inflammation 12 months post eradication.

摘要

患有囊性纤维化的婴幼儿何时感染铜绿假单胞菌?首次检测到这种细菌时能否将其根除?6岁以下儿童参与了澳大利亚珀斯一项基于年度支气管肺泡灌洗(BAL)的微生物监测项目。检测到铜绿假单胞菌时,采用静脉注射、口服和雾化抗生素联合治疗的根除方案。治疗3个月后进行重复BAL,以评估根除是否成功。33名(28.4%)儿童检测到铜绿假单胞菌;检测时的中位(范围)年龄为30.5(3.3 - 71.4)个月。33名患者中有6名(18.2%)在检测时铜绿假单胞菌呈黏液样,33名儿童中有16名(48.5%)伴有呼吸道症状。共有26名儿童接受了根除治疗,26名中有20名(77%)在一个根除周期后铜绿假单胞菌被根除,另外3名儿童(共88%)在第二个周期后被根除。根除与根除后12个月BAL液中中性粒细胞弹性蛋白酶和白细胞介素 - 1β显著降低有关。对于患有囊性纤维化的幼儿,使用静脉注射、口服和雾化抗生素联合治疗,在长达5年的时间里可以实现根除铜绿假单胞菌感染,并且根除后12个月肺部炎症会减轻。

相似文献

1
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis.囊性纤维化幼儿中铜绿假单胞菌的获得与清除
Eur Respir J. 2009 Feb;33(2):305-11. doi: 10.1183/09031936.00043108. Epub 2008 Nov 14.
2
Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.支气管肺泡灌洗导向治疗对囊性纤维化患儿铜绿假单胞菌感染和结构性肺损伤的影响:一项随机试验。
JAMA. 2011 Jul 13;306(2):163-71. doi: 10.1001/jama.2011.954.
3
Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis.支气管肺泡灌洗液中的氰化物对囊性纤维化患儿的铜绿假单胞菌并无诊断价值。
Eur Respir J. 2011 Mar;37(3):553-8. doi: 10.1183/09031936.00024210. Epub 2010 Jun 18.
4
Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症患者中铜绿假单胞菌清除治疗的结果。
Respir Med. 2012 Mar;106(3):356-60. doi: 10.1016/j.rmed.2011.11.018. Epub 2011 Dec 26.
5
Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years.5岁以下囊性纤维化患儿获得的铜绿假单胞菌基因型。
J Cyst Fibros. 2015 May;14(3):361-9. doi: 10.1016/j.jcf.2014.12.007. Epub 2015 Jan 3.
6
Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.通过新生儿筛查检测到的囊性纤维化婴儿的下呼吸道炎症。
Pediatr Pulmonol. 2005 Dec;40(6):500-10. doi: 10.1002/ppul.20294.
7
Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.铜绿假单胞菌在囊性纤维化患者中首次定植的地理差异。
Ann Am Thorac Soc. 2013 Apr;10(2):108-14. doi: 10.1513/AnnalsATS.201209-077OC.
8
Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis.儿童囊性纤维化患者肺部中单个微生物引起的炎症反应。
Clin Infect Dis. 2011 Sep;53(5):425-32. doi: 10.1093/cid/cir399.
9
Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.环丙沙星预防囊性纤维化患儿铜绿假单胞菌初始感染的对照试验
Thorax. 2010 Oct;65(10):915-20. doi: 10.1136/thx.2009.126128. Epub 2010 Aug 20.
10
Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.根除儿童早期铜绿假单胞菌感染的治疗方案不会促进该病原体产生抗生素耐药性。
J Cyst Fibros. 2009 Jan;8(1):43-6. doi: 10.1016/j.jcf.2008.08.001. Epub 2008 Oct 1.

引用本文的文献

1
Therapeutic Interventions for Infections in Cystic Fibrosis Patients: A Review of Phase IV Trials.囊性纤维化患者感染的治疗干预措施:IV期试验综述
J Clin Med. 2024 Oct 30;13(21):6530. doi: 10.3390/jcm13216530.
2
Pseudomonas aeruginosa senses and responds to epithelial potassium flux via Kdp operon to promote biofilm.铜绿假单胞菌通过 Kdp 操纵子感知和响应上皮细胞钾离子流,以促进生物膜的形成。
PLoS Pathog. 2024 May 31;20(5):e1011453. doi: 10.1371/journal.ppat.1011453. eCollection 2024 May.
3
Resistance genomics and molecular epidemiology of high-risk clones of ESBL-producing in young children.
儿童中产超广谱β-内酰胺酶(ESBL)高风险克隆的耐药基因组学和分子流行病学
Front Cell Infect Microbiol. 2023 May 24;13:1168096. doi: 10.3389/fcimb.2023.1168096. eCollection 2023.
4
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.治疗囊性纤维化患者铜绿假单胞菌感染的抗生素策略。
Cochrane Database Syst Rev. 2023 Jun 2;6(6):CD004197. doi: 10.1002/14651858.CD004197.pub6.
5
Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation.囊性纤维化骨病:CFTR 功能障碍与慢性炎症的相互作用。
Biomolecules. 2023 Feb 24;13(3):425. doi: 10.3390/biom13030425.
6
Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases.噬菌体:对抗慢性气道疾病中性粒细胞炎症的新型治疗手段。
Front Med (Lausanne). 2022 Dec 14;9:1069929. doi: 10.3389/fmed.2022.1069929. eCollection 2022.
7
Overcoming Barriers to Preventing and Treating Infections Using AAV Vectored Immunoprophylaxis.克服使用腺相关病毒载体免疫预防来预防和治疗感染的障碍。
Biomedicines. 2022 Dec 7;10(12):3162. doi: 10.3390/biomedicines10123162.
8
Pseudomonas aeruginosa modulates neutrophil granule exocytosis in an in vitro model of airway infection.铜绿假单胞菌在气道感染的体外模型中调节中性粒细胞颗粒胞吐。
Immunol Cell Biol. 2022 May;100(5):352-370. doi: 10.1111/imcb.12547. Epub 2022 Apr 11.
9
Anti-Inflammatory Effects of RTD-1 in a Murine Model of Chronic Lung Infection: Inhibition of NF-κB, Inflammasome Gene Expression, and Pro-IL-1β Biosynthesis.RTD-1在慢性肺部感染小鼠模型中的抗炎作用:对NF-κB、炎性小体基因表达及前白细胞介素-1β生物合成的抑制
Antibiotics (Basel). 2021 Aug 26;10(9):1043. doi: 10.3390/antibiotics10091043.
10
Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung.系统生物学与囊性纤维化肺部微生物群-宿主相互作用中的胆汁酸信号传导
Antibiotics (Basel). 2021 Jun 24;10(7):766. doi: 10.3390/antibiotics10070766.